Answers are grounded in this paper and cite their sources.
Case report uncovers therapeutic failure of common antivenom in Indigenous patient, suggesting need for alternative treatments.
Snakebites represent an important public health problem in tropical regions, especially in Indigenous and riverside areas of the Amazon. The genus Bothrops is responsible for most envenomations, with clinical manifestations that include bleeding, coagulopathies, and local necrosis. The treatment of choice is polyvalent antibothropic antivenom (SAB); however, there are rare reports of therapeutic inefficacy and response only to antivenom directed against Lachesis muta venom. Bothrops bilineatus, also known as the green jararaca, is an arboreal species whose venom may show regional variations that challenge conventional protocols. The present report describes an atypical clinical case caused by a rare Bothrops species, in which the patient presented severe failure to standard therapy and response only after use of antibothropic–lachetic antivenom (SABL). This is a 23-year-old male patient, Indigenous, admitted 6 hours after being bitten by a green jararaca on the right foot, presenting with local inflammation and gingival bleeding, receiving 8 vials of SAB. During the 72 hours after the initial antivenom therapy, he maintained hemorrhagic manifestations and prolonged coagulation times, receiving a total of 18 vials of SAB, without improvement. Four days after the accident, disseminated ecchymoses and hemorrhagic bullae appeared at the bite site, with the need for transfusion of blood products. In view of unequivocal failure of antibothropic antivenom therapy, 10 vials of SABL were administered, with global and lasting improvement thereafter. This case highlights a rare and severe therapeutic failure of SAB in a Bothrops bilineatus envenomation, with resolution only after use of SABL. The immediate clinical response to the alternative therapy suggests possible variability in the protein profile of the venom of the species involved, reinforcing the need to review protocols in endemic areas. Given the complexity of the case, the importance of serial laboratory monitoring, multidisciplinary action, and the availability of different antivenoms in referral centers is emphasized. In addition, the relevance of studies on the venom composition of specific species such as Bothrops bilineatus and its cross-reactivity with antivenoms intended for other snakes is reinforced. Cases like this contribute to improving therapeutic strategies and the continuous training of health professionals working in endemic regions of snakebite envenomation, especially in Indigenous territories.
No takes yet. Share an insight, caveat, or question.
Neves et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: